|Mr. James M. Corbett||Chief Exec. Officer, Pres, Director and Member of Exec. Committee||537.64k||N/A||58|
|Mr. Michael O'Neill FCMA||Chief Financial Officer, VP and Treasurer||341.5k||N/A||56|
|Mr. Michael Plunkett||Chief Operating Officer||331.8k||N/A||55|
|Mr. Ebun S. Garner Esq.||Sr. VP, Gen. Counsel and Corp. Sec.||286.5k||N/A||44|
|Mr. Mitsuo Asai||Pres of Alphatec Pacific Inc||407.07k||N/A||61|
Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, manufacture, and marketing of products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar, and intervertebral regions of the spine, as well as covers various spinal disorders and surgical procedures. The company offers cervical and cervico-thoracic products, including Trestle Luxe Anterior Cervical Plate System, Solanas Posterior Cervico/Thoracic Fixation System and Avalon Occipital Plate, and Pegasus Anchored Cervical Interbody system. It also provides thoracolumbar fixation products, such as Arsenal Degenerative System, Arsenal CBx Cortical Bone Fixation System, Zodiac Degenerative Spinal Fixation System, Zodiac Deformity Spinal Fixation System, and OsseoScrew Spinal Fixation System. In addition, the company offers spinal spacers comprising Battalion Universal Spacer System, Novel PEEK and Titanium Spinal Spacers, and Alphatec Solus Locking ALIF Spinal Spacer; and MIS Products consisting of Illico Minimally Invasive Surgery System and BridgePoint Spinous Process Fixation System. Further, it offers biologics, such as Neocore Osteoconductive Matrix, a synthetic scaffold for the regeneration of bone. The company sells its products through direct sales representatives and independent sales agents in the United States, as well as through independent distributors internationally. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Alphatec Holdings, Inc.’s ISS Governance QualityScore as of July 1, 2014 is 10. The pillar scores are Audit: 5; Board: 9; Shareholder Rights: 3; Compensation: 10.